title: Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.
abstract: During hematopoietic stem cell transplantation (HSCT), endothelial damage is the pathological hallmark of veno-occlusive disease of the liver, thrombotic microangiopathy, capillary leak syndrome and graft-versus-host disease. Events prior to conditioning, the conditioning regimen itself as well as calcineurin inhibitors may all induce endothelial damage. Unfortunately, the relative importance of these factors and their interactions, the time frame of endothelial damage and individual susceptibility remain unknown. Moreover, it is conceivable that conditioning regimens differ markedly in their propensity to initiate endothelial damage. Monitoring endothelial damage and response to treatment is hampered by the current lack of suitable markers. In this regard, an ideal marker should be sensitive and specific and indicate the development of an endothelial disorder prior to the onset of symptoms and organ dysfunction. Soluble markers, such as thrombomodulin, are easily amenable with immunoassays; yet, the interpretation of their levels is hampered by the influence of comorbidity. Evaluation of circulating endothelial cells in HSCT demonstrated a marked and dose-dependent increase in cell numbers after conditioning. The challenge ahead is to establish and evaluate novel markers of endothelial damage to permit early detection of disease, monitor response to treatment and evaluate different conditioning regimens.
authors.affiliation: Division of Nephrology, Department of Medicine, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. Woywodt.Alexander@MH-Hannover.de
authors.forename: A
authors.initials: A
authors.lastname: Woywodt
authors.forename: M
authors.initials: M
authors.lastname: Haubitz
authors.forename: S
authors.initials: S
authors.lastname: Buchholz
authors.forename: B
authors.initials: B
authors.lastname: Hertenstein
mesh_terms: D015415:Biomarkers / Q000097:blood; D004730:Endothelium, Vascular / Q000473:pathology*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D019172:Transplantation Conditioning / Q000009:adverse effects
chemical_list: D015415:Biomarkers